Global Dyslexia Treatment Market

Dyslexia Treatment Comprehensive Study by Type (Phonological Dyslexia, Surface Dyslexia), Treatment (Drug Class, Tools, Educational Techniques), End-users (Hospitals, Home Care, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Other) Players and Region - Global Market Outlook to 2028

Dyslexia Treatment Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Dyslexia Treatment
Dyslexia is a learning disability that makes reading and language-related tasks harder. It happens because of disruptions in how your brain processes writing so you can understand it. Most people learn they have dyslexia during childhood, and it’s typically a lifelong issue. Educational interventions can teach effective new ways to learn and read. Children with dyslexia may work with a trained specialist to learn new reading skills. Sometimes, slowing down a lesson gives a child with dyslexia more time to cover topics. This form of dyslexia is also known as “developmental dyslexia.” The dyslexia treatment market is poised for continued growth and innovation. Continued advancements in technology, personalized learning, and collaborative efforts hold immense potential to improve the lives of individuals with dyslexia, empowering them to reach their full potential.

AttributesDetails
Study Period2018-2028
Base Year2022
UnitValue (USD Million)


The companies are exploring the market by adopting expansions, investments, new service launches and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain a competitive advantage through combined collaborations. Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Dyslexia Treatment market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Teva Pharmaceutical Industries Ltd (Israel), Eli Lilly & Company (United States), Novartis AG (United Kingdom), Purdue Pharma (United States), Pfizer Inc. (United States), Jubilant Cadista (United States), Micro Labs (India), Srikem Labs (India) and Gangwal Chemicals Pvt. Ltd (India) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are RPG Life Sciences Ltd (India), Wallace Pharmaceuticals Ltd (United States), Cian Healthcare Pvt Ltd (India) and GlaxoSmithKline (United Kingdom).

Segmentation Overview
AMA Research has segmented the market of Global Dyslexia Treatment market by Type (Phonological Dyslexia and Surface Dyslexia) and Region.



On the basis of geography, the market of Dyslexia Treatment has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Treatment, the sub-segment i.e. Drug Class will boost the Dyslexia Treatment market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End-users, the sub-segment i.e. Hospitals will boost the Dyslexia Treatment market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Distribution Channel, the sub-segment i.e. Hospital Pharmacies will boost the Dyslexia Treatment market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Increasing Awareness about Dyslexia and its Treatment Options among People

Market Growth Drivers:
Increased Prevalence of Dyslexia Worldwide, Rise in the Number of New Diagnostic Centres and Hospitals and Growth in Healthcare Infrastructure in Developing Regions

Challenges:
Lack of Healthcare Infrastructure in Underdeveloped Countries

Restraints:
Unavailability of Complete Cure for Dyslexia Disorder

Opportunities:
Increased Research and Development Funding, Growth in the Healthcare Industry Worldwide and Increasing Government Initiatives for Dyslexia Awareness

Market Leaders and their expansionary development strategies
In November 2023, Luminosity and the European Dyslexia Association (EDA) Partnered to offer Luminosity's brain training games and cognitive assessments with reduced subscription fees for members of the EDA, promoting affordable access to cognitive training for individuals with dyslexia in Europe.
In October 2023, Lumosity introduced a brain training program specifically designed for individuals with dyslexia, targeting cognitive skills like auditory processing and visual memory to enhance reading ability.


Key Target Audience
Dyslexia Treatment Providers, Distributors, Emerging Companies, Research Professionals and End-users

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Phonological Dyslexia
  • Surface Dyslexia
By Treatment
  • Drug Class
  • Tools
  • Educational Techniques

By End-users
  • Hospitals
  • Home Care
  • Others

By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Other

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increased Prevalence of Dyslexia Worldwide
      • 3.2.2. Rise in the Number of New Diagnostic Centres and Hospitals
      • 3.2.3. Growth in Healthcare Infrastructure in Developing Regions
    • 3.3. Market Challenges
      • 3.3.1. Lack of Healthcare Infrastructure in Underdeveloped Countries
    • 3.4. Market Trends
      • 3.4.1. Increasing Awareness about Dyslexia and its Treatment Options among People
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Dyslexia Treatment, by Type, Treatment, End-users, Distribution Channel and Region (value) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Dyslexia Treatment (Value)
      • 5.2.1. Global Dyslexia Treatment by: Type (Value)
        • 5.2.1.1. Phonological Dyslexia
        • 5.2.1.2. Surface Dyslexia
      • 5.2.2. Global Dyslexia Treatment by: Treatment (Value)
        • 5.2.2.1. Drug Class
        • 5.2.2.2. Tools
        • 5.2.2.3. Educational Techniques
      • 5.2.3. Global Dyslexia Treatment by: End-users (Value)
        • 5.2.3.1. Hospitals
        • 5.2.3.2. Home Care
        • 5.2.3.3. Others
      • 5.2.4. Global Dyslexia Treatment by: Distribution Channel (Value)
        • 5.2.4.1. Hospital Pharmacies
        • 5.2.4.2. Retail Pharmacies
        • 5.2.4.3. Other
      • 5.2.5. Global Dyslexia Treatment Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Dyslexia Treatment: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Teva Pharmaceutical Industries Ltd (Israel)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Eli Lilly & Company (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Novartis AG (United Kingdom)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Purdue Pharma (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Pfizer Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Jubilant Cadista (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Micro Labs (India)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Srikem Labs (India)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Gangwal Chemicals Pvt. Ltd (India)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
  • 7. Global Dyslexia Treatment Sale, by Type, Treatment, End-users, Distribution Channel and Region (value) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Dyslexia Treatment (Value)
      • 7.2.1. Global Dyslexia Treatment by: Type (Value)
        • 7.2.1.1. Phonological Dyslexia
        • 7.2.1.2. Surface Dyslexia
      • 7.2.2. Global Dyslexia Treatment by: Treatment (Value)
        • 7.2.2.1. Drug Class
        • 7.2.2.2. Tools
        • 7.2.2.3. Educational Techniques
      • 7.2.3. Global Dyslexia Treatment by: End-users (Value)
        • 7.2.3.1. Hospitals
        • 7.2.3.2. Home Care
        • 7.2.3.3. Others
      • 7.2.4. Global Dyslexia Treatment by: Distribution Channel (Value)
        • 7.2.4.1. Hospital Pharmacies
        • 7.2.4.2. Retail Pharmacies
        • 7.2.4.3. Other
      • 7.2.5. Global Dyslexia Treatment Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Dyslexia Treatment: by Type(USD Million)
  • Table 2. Dyslexia Treatment Phonological Dyslexia , by Region USD Million (2017-2022)
  • Table 3. Dyslexia Treatment Surface Dyslexia , by Region USD Million (2017-2022)
  • Table 4. Dyslexia Treatment: by Treatment(USD Million)
  • Table 5. Dyslexia Treatment Drug Class , by Region USD Million (2017-2022)
  • Table 6. Dyslexia Treatment Tools , by Region USD Million (2017-2022)
  • Table 7. Dyslexia Treatment Educational Techniques , by Region USD Million (2017-2022)
  • Table 8. Dyslexia Treatment: by End-users(USD Million)
  • Table 9. Dyslexia Treatment Hospitals , by Region USD Million (2017-2022)
  • Table 10. Dyslexia Treatment Home Care , by Region USD Million (2017-2022)
  • Table 11. Dyslexia Treatment Others , by Region USD Million (2017-2022)
  • Table 12. Dyslexia Treatment: by Distribution Channel(USD Million)
  • Table 13. Dyslexia Treatment Hospital Pharmacies , by Region USD Million (2017-2022)
  • Table 14. Dyslexia Treatment Retail Pharmacies , by Region USD Million (2017-2022)
  • Table 15. Dyslexia Treatment Other , by Region USD Million (2017-2022)
  • Table 16. South America Dyslexia Treatment, by Country USD Million (2017-2022)
  • Table 17. South America Dyslexia Treatment, by Type USD Million (2017-2022)
  • Table 18. South America Dyslexia Treatment, by Treatment USD Million (2017-2022)
  • Table 19. South America Dyslexia Treatment, by End-users USD Million (2017-2022)
  • Table 20. South America Dyslexia Treatment, by Distribution Channel USD Million (2017-2022)
  • Table 21. Brazil Dyslexia Treatment, by Type USD Million (2017-2022)
  • Table 22. Brazil Dyslexia Treatment, by Treatment USD Million (2017-2022)
  • Table 23. Brazil Dyslexia Treatment, by End-users USD Million (2017-2022)
  • Table 24. Brazil Dyslexia Treatment, by Distribution Channel USD Million (2017-2022)
  • Table 25. Argentina Dyslexia Treatment, by Type USD Million (2017-2022)
  • Table 26. Argentina Dyslexia Treatment, by Treatment USD Million (2017-2022)
  • Table 27. Argentina Dyslexia Treatment, by End-users USD Million (2017-2022)
  • Table 28. Argentina Dyslexia Treatment, by Distribution Channel USD Million (2017-2022)
  • Table 29. Rest of South America Dyslexia Treatment, by Type USD Million (2017-2022)
  • Table 30. Rest of South America Dyslexia Treatment, by Treatment USD Million (2017-2022)
  • Table 31. Rest of South America Dyslexia Treatment, by End-users USD Million (2017-2022)
  • Table 32. Rest of South America Dyslexia Treatment, by Distribution Channel USD Million (2017-2022)
  • Table 33. Asia Pacific Dyslexia Treatment, by Country USD Million (2017-2022)
  • Table 34. Asia Pacific Dyslexia Treatment, by Type USD Million (2017-2022)
  • Table 35. Asia Pacific Dyslexia Treatment, by Treatment USD Million (2017-2022)
  • Table 36. Asia Pacific Dyslexia Treatment, by End-users USD Million (2017-2022)
  • Table 37. Asia Pacific Dyslexia Treatment, by Distribution Channel USD Million (2017-2022)
  • Table 38. China Dyslexia Treatment, by Type USD Million (2017-2022)
  • Table 39. China Dyslexia Treatment, by Treatment USD Million (2017-2022)
  • Table 40. China Dyslexia Treatment, by End-users USD Million (2017-2022)
  • Table 41. China Dyslexia Treatment, by Distribution Channel USD Million (2017-2022)
  • Table 42. Japan Dyslexia Treatment, by Type USD Million (2017-2022)
  • Table 43. Japan Dyslexia Treatment, by Treatment USD Million (2017-2022)
  • Table 44. Japan Dyslexia Treatment, by End-users USD Million (2017-2022)
  • Table 45. Japan Dyslexia Treatment, by Distribution Channel USD Million (2017-2022)
  • Table 46. India Dyslexia Treatment, by Type USD Million (2017-2022)
  • Table 47. India Dyslexia Treatment, by Treatment USD Million (2017-2022)
  • Table 48. India Dyslexia Treatment, by End-users USD Million (2017-2022)
  • Table 49. India Dyslexia Treatment, by Distribution Channel USD Million (2017-2022)
  • Table 50. South Korea Dyslexia Treatment, by Type USD Million (2017-2022)
  • Table 51. South Korea Dyslexia Treatment, by Treatment USD Million (2017-2022)
  • Table 52. South Korea Dyslexia Treatment, by End-users USD Million (2017-2022)
  • Table 53. South Korea Dyslexia Treatment, by Distribution Channel USD Million (2017-2022)
  • Table 54. Taiwan Dyslexia Treatment, by Type USD Million (2017-2022)
  • Table 55. Taiwan Dyslexia Treatment, by Treatment USD Million (2017-2022)
  • Table 56. Taiwan Dyslexia Treatment, by End-users USD Million (2017-2022)
  • Table 57. Taiwan Dyslexia Treatment, by Distribution Channel USD Million (2017-2022)
  • Table 58. Australia Dyslexia Treatment, by Type USD Million (2017-2022)
  • Table 59. Australia Dyslexia Treatment, by Treatment USD Million (2017-2022)
  • Table 60. Australia Dyslexia Treatment, by End-users USD Million (2017-2022)
  • Table 61. Australia Dyslexia Treatment, by Distribution Channel USD Million (2017-2022)
  • Table 62. Rest of Asia-Pacific Dyslexia Treatment, by Type USD Million (2017-2022)
  • Table 63. Rest of Asia-Pacific Dyslexia Treatment, by Treatment USD Million (2017-2022)
  • Table 64. Rest of Asia-Pacific Dyslexia Treatment, by End-users USD Million (2017-2022)
  • Table 65. Rest of Asia-Pacific Dyslexia Treatment, by Distribution Channel USD Million (2017-2022)
  • Table 66. Europe Dyslexia Treatment, by Country USD Million (2017-2022)
  • Table 67. Europe Dyslexia Treatment, by Type USD Million (2017-2022)
  • Table 68. Europe Dyslexia Treatment, by Treatment USD Million (2017-2022)
  • Table 69. Europe Dyslexia Treatment, by End-users USD Million (2017-2022)
  • Table 70. Europe Dyslexia Treatment, by Distribution Channel USD Million (2017-2022)
  • Table 71. Germany Dyslexia Treatment, by Type USD Million (2017-2022)
  • Table 72. Germany Dyslexia Treatment, by Treatment USD Million (2017-2022)
  • Table 73. Germany Dyslexia Treatment, by End-users USD Million (2017-2022)
  • Table 74. Germany Dyslexia Treatment, by Distribution Channel USD Million (2017-2022)
  • Table 75. France Dyslexia Treatment, by Type USD Million (2017-2022)
  • Table 76. France Dyslexia Treatment, by Treatment USD Million (2017-2022)
  • Table 77. France Dyslexia Treatment, by End-users USD Million (2017-2022)
  • Table 78. France Dyslexia Treatment, by Distribution Channel USD Million (2017-2022)
  • Table 79. Italy Dyslexia Treatment, by Type USD Million (2017-2022)
  • Table 80. Italy Dyslexia Treatment, by Treatment USD Million (2017-2022)
  • Table 81. Italy Dyslexia Treatment, by End-users USD Million (2017-2022)
  • Table 82. Italy Dyslexia Treatment, by Distribution Channel USD Million (2017-2022)
  • Table 83. United Kingdom Dyslexia Treatment, by Type USD Million (2017-2022)
  • Table 84. United Kingdom Dyslexia Treatment, by Treatment USD Million (2017-2022)
  • Table 85. United Kingdom Dyslexia Treatment, by End-users USD Million (2017-2022)
  • Table 86. United Kingdom Dyslexia Treatment, by Distribution Channel USD Million (2017-2022)
  • Table 87. Netherlands Dyslexia Treatment, by Type USD Million (2017-2022)
  • Table 88. Netherlands Dyslexia Treatment, by Treatment USD Million (2017-2022)
  • Table 89. Netherlands Dyslexia Treatment, by End-users USD Million (2017-2022)
  • Table 90. Netherlands Dyslexia Treatment, by Distribution Channel USD Million (2017-2022)
  • Table 91. Rest of Europe Dyslexia Treatment, by Type USD Million (2017-2022)
  • Table 92. Rest of Europe Dyslexia Treatment, by Treatment USD Million (2017-2022)
  • Table 93. Rest of Europe Dyslexia Treatment, by End-users USD Million (2017-2022)
  • Table 94. Rest of Europe Dyslexia Treatment, by Distribution Channel USD Million (2017-2022)
  • Table 95. MEA Dyslexia Treatment, by Country USD Million (2017-2022)
  • Table 96. MEA Dyslexia Treatment, by Type USD Million (2017-2022)
  • Table 97. MEA Dyslexia Treatment, by Treatment USD Million (2017-2022)
  • Table 98. MEA Dyslexia Treatment, by End-users USD Million (2017-2022)
  • Table 99. MEA Dyslexia Treatment, by Distribution Channel USD Million (2017-2022)
  • Table 100. Middle East Dyslexia Treatment, by Type USD Million (2017-2022)
  • Table 101. Middle East Dyslexia Treatment, by Treatment USD Million (2017-2022)
  • Table 102. Middle East Dyslexia Treatment, by End-users USD Million (2017-2022)
  • Table 103. Middle East Dyslexia Treatment, by Distribution Channel USD Million (2017-2022)
  • Table 104. Africa Dyslexia Treatment, by Type USD Million (2017-2022)
  • Table 105. Africa Dyslexia Treatment, by Treatment USD Million (2017-2022)
  • Table 106. Africa Dyslexia Treatment, by End-users USD Million (2017-2022)
  • Table 107. Africa Dyslexia Treatment, by Distribution Channel USD Million (2017-2022)
  • Table 108. North America Dyslexia Treatment, by Country USD Million (2017-2022)
  • Table 109. North America Dyslexia Treatment, by Type USD Million (2017-2022)
  • Table 110. North America Dyslexia Treatment, by Treatment USD Million (2017-2022)
  • Table 111. North America Dyslexia Treatment, by End-users USD Million (2017-2022)
  • Table 112. North America Dyslexia Treatment, by Distribution Channel USD Million (2017-2022)
  • Table 113. United States Dyslexia Treatment, by Type USD Million (2017-2022)
  • Table 114. United States Dyslexia Treatment, by Treatment USD Million (2017-2022)
  • Table 115. United States Dyslexia Treatment, by End-users USD Million (2017-2022)
  • Table 116. United States Dyslexia Treatment, by Distribution Channel USD Million (2017-2022)
  • Table 117. Canada Dyslexia Treatment, by Type USD Million (2017-2022)
  • Table 118. Canada Dyslexia Treatment, by Treatment USD Million (2017-2022)
  • Table 119. Canada Dyslexia Treatment, by End-users USD Million (2017-2022)
  • Table 120. Canada Dyslexia Treatment, by Distribution Channel USD Million (2017-2022)
  • Table 121. Mexico Dyslexia Treatment, by Type USD Million (2017-2022)
  • Table 122. Mexico Dyslexia Treatment, by Treatment USD Million (2017-2022)
  • Table 123. Mexico Dyslexia Treatment, by End-users USD Million (2017-2022)
  • Table 124. Mexico Dyslexia Treatment, by Distribution Channel USD Million (2017-2022)
  • Table 125. Company Basic Information, Sales Area and Its Competitors
  • Table 126. Company Basic Information, Sales Area and Its Competitors
  • Table 127. Company Basic Information, Sales Area and Its Competitors
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Company Basic Information, Sales Area and Its Competitors
  • Table 134. Dyslexia Treatment: by Type(USD Million)
  • Table 135. Dyslexia Treatment Phonological Dyslexia , by Region USD Million (2023-2028)
  • Table 136. Dyslexia Treatment Surface Dyslexia , by Region USD Million (2023-2028)
  • Table 137. Dyslexia Treatment: by Treatment(USD Million)
  • Table 138. Dyslexia Treatment Drug Class , by Region USD Million (2023-2028)
  • Table 139. Dyslexia Treatment Tools , by Region USD Million (2023-2028)
  • Table 140. Dyslexia Treatment Educational Techniques , by Region USD Million (2023-2028)
  • Table 141. Dyslexia Treatment: by End-users(USD Million)
  • Table 142. Dyslexia Treatment Hospitals , by Region USD Million (2023-2028)
  • Table 143. Dyslexia Treatment Home Care , by Region USD Million (2023-2028)
  • Table 144. Dyslexia Treatment Others , by Region USD Million (2023-2028)
  • Table 145. Dyslexia Treatment: by Distribution Channel(USD Million)
  • Table 146. Dyslexia Treatment Hospital Pharmacies , by Region USD Million (2023-2028)
  • Table 147. Dyslexia Treatment Retail Pharmacies , by Region USD Million (2023-2028)
  • Table 148. Dyslexia Treatment Other , by Region USD Million (2023-2028)
  • Table 149. South America Dyslexia Treatment, by Country USD Million (2023-2028)
  • Table 150. South America Dyslexia Treatment, by Type USD Million (2023-2028)
  • Table 151. South America Dyslexia Treatment, by Treatment USD Million (2023-2028)
  • Table 152. South America Dyslexia Treatment, by End-users USD Million (2023-2028)
  • Table 153. South America Dyslexia Treatment, by Distribution Channel USD Million (2023-2028)
  • Table 154. Brazil Dyslexia Treatment, by Type USD Million (2023-2028)
  • Table 155. Brazil Dyslexia Treatment, by Treatment USD Million (2023-2028)
  • Table 156. Brazil Dyslexia Treatment, by End-users USD Million (2023-2028)
  • Table 157. Brazil Dyslexia Treatment, by Distribution Channel USD Million (2023-2028)
  • Table 158. Argentina Dyslexia Treatment, by Type USD Million (2023-2028)
  • Table 159. Argentina Dyslexia Treatment, by Treatment USD Million (2023-2028)
  • Table 160. Argentina Dyslexia Treatment, by End-users USD Million (2023-2028)
  • Table 161. Argentina Dyslexia Treatment, by Distribution Channel USD Million (2023-2028)
  • Table 162. Rest of South America Dyslexia Treatment, by Type USD Million (2023-2028)
  • Table 163. Rest of South America Dyslexia Treatment, by Treatment USD Million (2023-2028)
  • Table 164. Rest of South America Dyslexia Treatment, by End-users USD Million (2023-2028)
  • Table 165. Rest of South America Dyslexia Treatment, by Distribution Channel USD Million (2023-2028)
  • Table 166. Asia Pacific Dyslexia Treatment, by Country USD Million (2023-2028)
  • Table 167. Asia Pacific Dyslexia Treatment, by Type USD Million (2023-2028)
  • Table 168. Asia Pacific Dyslexia Treatment, by Treatment USD Million (2023-2028)
  • Table 169. Asia Pacific Dyslexia Treatment, by End-users USD Million (2023-2028)
  • Table 170. Asia Pacific Dyslexia Treatment, by Distribution Channel USD Million (2023-2028)
  • Table 171. China Dyslexia Treatment, by Type USD Million (2023-2028)
  • Table 172. China Dyslexia Treatment, by Treatment USD Million (2023-2028)
  • Table 173. China Dyslexia Treatment, by End-users USD Million (2023-2028)
  • Table 174. China Dyslexia Treatment, by Distribution Channel USD Million (2023-2028)
  • Table 175. Japan Dyslexia Treatment, by Type USD Million (2023-2028)
  • Table 176. Japan Dyslexia Treatment, by Treatment USD Million (2023-2028)
  • Table 177. Japan Dyslexia Treatment, by End-users USD Million (2023-2028)
  • Table 178. Japan Dyslexia Treatment, by Distribution Channel USD Million (2023-2028)
  • Table 179. India Dyslexia Treatment, by Type USD Million (2023-2028)
  • Table 180. India Dyslexia Treatment, by Treatment USD Million (2023-2028)
  • Table 181. India Dyslexia Treatment, by End-users USD Million (2023-2028)
  • Table 182. India Dyslexia Treatment, by Distribution Channel USD Million (2023-2028)
  • Table 183. South Korea Dyslexia Treatment, by Type USD Million (2023-2028)
  • Table 184. South Korea Dyslexia Treatment, by Treatment USD Million (2023-2028)
  • Table 185. South Korea Dyslexia Treatment, by End-users USD Million (2023-2028)
  • Table 186. South Korea Dyslexia Treatment, by Distribution Channel USD Million (2023-2028)
  • Table 187. Taiwan Dyslexia Treatment, by Type USD Million (2023-2028)
  • Table 188. Taiwan Dyslexia Treatment, by Treatment USD Million (2023-2028)
  • Table 189. Taiwan Dyslexia Treatment, by End-users USD Million (2023-2028)
  • Table 190. Taiwan Dyslexia Treatment, by Distribution Channel USD Million (2023-2028)
  • Table 191. Australia Dyslexia Treatment, by Type USD Million (2023-2028)
  • Table 192. Australia Dyslexia Treatment, by Treatment USD Million (2023-2028)
  • Table 193. Australia Dyslexia Treatment, by End-users USD Million (2023-2028)
  • Table 194. Australia Dyslexia Treatment, by Distribution Channel USD Million (2023-2028)
  • Table 195. Rest of Asia-Pacific Dyslexia Treatment, by Type USD Million (2023-2028)
  • Table 196. Rest of Asia-Pacific Dyslexia Treatment, by Treatment USD Million (2023-2028)
  • Table 197. Rest of Asia-Pacific Dyslexia Treatment, by End-users USD Million (2023-2028)
  • Table 198. Rest of Asia-Pacific Dyslexia Treatment, by Distribution Channel USD Million (2023-2028)
  • Table 199. Europe Dyslexia Treatment, by Country USD Million (2023-2028)
  • Table 200. Europe Dyslexia Treatment, by Type USD Million (2023-2028)
  • Table 201. Europe Dyslexia Treatment, by Treatment USD Million (2023-2028)
  • Table 202. Europe Dyslexia Treatment, by End-users USD Million (2023-2028)
  • Table 203. Europe Dyslexia Treatment, by Distribution Channel USD Million (2023-2028)
  • Table 204. Germany Dyslexia Treatment, by Type USD Million (2023-2028)
  • Table 205. Germany Dyslexia Treatment, by Treatment USD Million (2023-2028)
  • Table 206. Germany Dyslexia Treatment, by End-users USD Million (2023-2028)
  • Table 207. Germany Dyslexia Treatment, by Distribution Channel USD Million (2023-2028)
  • Table 208. France Dyslexia Treatment, by Type USD Million (2023-2028)
  • Table 209. France Dyslexia Treatment, by Treatment USD Million (2023-2028)
  • Table 210. France Dyslexia Treatment, by End-users USD Million (2023-2028)
  • Table 211. France Dyslexia Treatment, by Distribution Channel USD Million (2023-2028)
  • Table 212. Italy Dyslexia Treatment, by Type USD Million (2023-2028)
  • Table 213. Italy Dyslexia Treatment, by Treatment USD Million (2023-2028)
  • Table 214. Italy Dyslexia Treatment, by End-users USD Million (2023-2028)
  • Table 215. Italy Dyslexia Treatment, by Distribution Channel USD Million (2023-2028)
  • Table 216. United Kingdom Dyslexia Treatment, by Type USD Million (2023-2028)
  • Table 217. United Kingdom Dyslexia Treatment, by Treatment USD Million (2023-2028)
  • Table 218. United Kingdom Dyslexia Treatment, by End-users USD Million (2023-2028)
  • Table 219. United Kingdom Dyslexia Treatment, by Distribution Channel USD Million (2023-2028)
  • Table 220. Netherlands Dyslexia Treatment, by Type USD Million (2023-2028)
  • Table 221. Netherlands Dyslexia Treatment, by Treatment USD Million (2023-2028)
  • Table 222. Netherlands Dyslexia Treatment, by End-users USD Million (2023-2028)
  • Table 223. Netherlands Dyslexia Treatment, by Distribution Channel USD Million (2023-2028)
  • Table 224. Rest of Europe Dyslexia Treatment, by Type USD Million (2023-2028)
  • Table 225. Rest of Europe Dyslexia Treatment, by Treatment USD Million (2023-2028)
  • Table 226. Rest of Europe Dyslexia Treatment, by End-users USD Million (2023-2028)
  • Table 227. Rest of Europe Dyslexia Treatment, by Distribution Channel USD Million (2023-2028)
  • Table 228. MEA Dyslexia Treatment, by Country USD Million (2023-2028)
  • Table 229. MEA Dyslexia Treatment, by Type USD Million (2023-2028)
  • Table 230. MEA Dyslexia Treatment, by Treatment USD Million (2023-2028)
  • Table 231. MEA Dyslexia Treatment, by End-users USD Million (2023-2028)
  • Table 232. MEA Dyslexia Treatment, by Distribution Channel USD Million (2023-2028)
  • Table 233. Middle East Dyslexia Treatment, by Type USD Million (2023-2028)
  • Table 234. Middle East Dyslexia Treatment, by Treatment USD Million (2023-2028)
  • Table 235. Middle East Dyslexia Treatment, by End-users USD Million (2023-2028)
  • Table 236. Middle East Dyslexia Treatment, by Distribution Channel USD Million (2023-2028)
  • Table 237. Africa Dyslexia Treatment, by Type USD Million (2023-2028)
  • Table 238. Africa Dyslexia Treatment, by Treatment USD Million (2023-2028)
  • Table 239. Africa Dyslexia Treatment, by End-users USD Million (2023-2028)
  • Table 240. Africa Dyslexia Treatment, by Distribution Channel USD Million (2023-2028)
  • Table 241. North America Dyslexia Treatment, by Country USD Million (2023-2028)
  • Table 242. North America Dyslexia Treatment, by Type USD Million (2023-2028)
  • Table 243. North America Dyslexia Treatment, by Treatment USD Million (2023-2028)
  • Table 244. North America Dyslexia Treatment, by End-users USD Million (2023-2028)
  • Table 245. North America Dyslexia Treatment, by Distribution Channel USD Million (2023-2028)
  • Table 246. United States Dyslexia Treatment, by Type USD Million (2023-2028)
  • Table 247. United States Dyslexia Treatment, by Treatment USD Million (2023-2028)
  • Table 248. United States Dyslexia Treatment, by End-users USD Million (2023-2028)
  • Table 249. United States Dyslexia Treatment, by Distribution Channel USD Million (2023-2028)
  • Table 250. Canada Dyslexia Treatment, by Type USD Million (2023-2028)
  • Table 251. Canada Dyslexia Treatment, by Treatment USD Million (2023-2028)
  • Table 252. Canada Dyslexia Treatment, by End-users USD Million (2023-2028)
  • Table 253. Canada Dyslexia Treatment, by Distribution Channel USD Million (2023-2028)
  • Table 254. Mexico Dyslexia Treatment, by Type USD Million (2023-2028)
  • Table 255. Mexico Dyslexia Treatment, by Treatment USD Million (2023-2028)
  • Table 256. Mexico Dyslexia Treatment, by End-users USD Million (2023-2028)
  • Table 257. Mexico Dyslexia Treatment, by Distribution Channel USD Million (2023-2028)
  • Table 258. Research Programs/Design for This Report
  • Table 259. Key Data Information from Secondary Sources
  • Table 260. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Dyslexia Treatment: by Type USD Million (2017-2022)
  • Figure 5. Global Dyslexia Treatment: by Treatment USD Million (2017-2022)
  • Figure 6. Global Dyslexia Treatment: by End-users USD Million (2017-2022)
  • Figure 7. Global Dyslexia Treatment: by Distribution Channel USD Million (2017-2022)
  • Figure 8. South America Dyslexia Treatment Share (%), by Country
  • Figure 9. Asia Pacific Dyslexia Treatment Share (%), by Country
  • Figure 10. Europe Dyslexia Treatment Share (%), by Country
  • Figure 11. MEA Dyslexia Treatment Share (%), by Country
  • Figure 12. North America Dyslexia Treatment Share (%), by Country
  • Figure 13. Global Dyslexia Treatment share by Players 2022 (%)
  • Figure 14. Global Dyslexia Treatment share by Players (Top 3) 2022(%)
  • Figure 15. Global Dyslexia Treatment share by Players (Top 5) 2022(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Teva Pharmaceutical Industries Ltd (Israel) Revenue, Net Income and Gross profit
  • Figure 18. Teva Pharmaceutical Industries Ltd (Israel) Revenue: by Geography 2022
  • Figure 19. Eli Lilly & Company (United States) Revenue, Net Income and Gross profit
  • Figure 20. Eli Lilly & Company (United States) Revenue: by Geography 2022
  • Figure 21. Novartis AG (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 22. Novartis AG (United Kingdom) Revenue: by Geography 2022
  • Figure 23. Purdue Pharma (United States) Revenue, Net Income and Gross profit
  • Figure 24. Purdue Pharma (United States) Revenue: by Geography 2022
  • Figure 25. Pfizer Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. Pfizer Inc. (United States) Revenue: by Geography 2022
  • Figure 27. Jubilant Cadista (United States) Revenue, Net Income and Gross profit
  • Figure 28. Jubilant Cadista (United States) Revenue: by Geography 2022
  • Figure 29. Micro Labs (India) Revenue, Net Income and Gross profit
  • Figure 30. Micro Labs (India) Revenue: by Geography 2022
  • Figure 31. Srikem Labs (India) Revenue, Net Income and Gross profit
  • Figure 32. Srikem Labs (India) Revenue: by Geography 2022
  • Figure 33. Gangwal Chemicals Pvt. Ltd (India) Revenue, Net Income and Gross profit
  • Figure 34. Gangwal Chemicals Pvt. Ltd (India) Revenue: by Geography 2022
  • Figure 35. Global Dyslexia Treatment: by Type USD Million (2023-2028)
  • Figure 36. Global Dyslexia Treatment: by Treatment USD Million (2023-2028)
  • Figure 37. Global Dyslexia Treatment: by End-users USD Million (2023-2028)
  • Figure 38. Global Dyslexia Treatment: by Distribution Channel USD Million (2023-2028)
  • Figure 39. South America Dyslexia Treatment Share (%), by Country
  • Figure 40. Asia Pacific Dyslexia Treatment Share (%), by Country
  • Figure 41. Europe Dyslexia Treatment Share (%), by Country
  • Figure 42. MEA Dyslexia Treatment Share (%), by Country
  • Figure 43. North America Dyslexia Treatment Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Teva Pharmaceutical Industries Ltd (Israel)
  • Eli Lilly & Company (United States)
  • Novartis AG (United Kingdom)
  • Purdue Pharma (United States)
  • Pfizer Inc. (United States)
  • Jubilant Cadista (United States)
  • Micro Labs (India)
  • Srikem Labs (India)
  • Gangwal Chemicals Pvt. Ltd (India)
Additional players considered in the study are as follows:
RPG Life Sciences Ltd (India) , Wallace Pharmaceuticals Ltd (United States) , Cian Healthcare Pvt Ltd (India) , GlaxoSmithKline (United Kingdom)
Select User Access Type

Key Highlights of Report


Dec 2023 219 Pages 57 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Dyslexia Treatment Market Quantitative research analysis
Global Dyslexia Treatment Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Teva Pharmaceutical Industries Ltd (Israel), Eli Lilly & Company (United States), Novartis AG (United Kingdom), Purdue Pharma (United States), Pfizer Inc. (United States), Jubilant Cadista (United States), Micro Labs (India), Srikem Labs (India) and Gangwal Chemicals Pvt. Ltd (India) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Increasing Awareness about Dyslexia and its Treatment Options among People" is seen as one of major influencing trends for Dyslexia Treatment Market during projected period 2022-2028.
The Dyslexia Treatment market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Dyslexia Treatment Market Report?

Have a Query? Click Here

Other Related Reports

Deep Vein Thrombosis Treatment Comprehensive Study by Type (Medication, Devices, Surgery), Application (Pulmonary Embolism, Atrial Fibrillation, Deep Vein Thrombosis, Other), End Users (Hospitals, Ho...
$ 3750
Veterinary Artificial Insemination Comprehensive Study by Type (Equipment (Semen Applicator, Insemination Gun, Others), Consumables (Sheath, Lubricant, Glove, Heat Detector, Others), Accessories), An...
$ 3650
Dent Disease Treatment Comprehensive Study by Drug Type (Calcium Phosphate, Cysteine, Angiotensin-Converting Enzyme (ACE) Inhibitor, Angiotensin Receptor Blockers, Uric Acid, Calcium Oxalate, Thiazid...
$ 3750
Rhinoplasty Comprehensive Study by Type (Closed Rhinoplasty hidden inside the nose., Open Rhinoplasty, Filler Rhinoplasty, Revision Rhinoplasty), Application (Power setting of the console,, Density o...
$ 3450
Oculoplastic Surgery Comprehensive Study by Type (Blepharoplasty, Ptosis Repair, Entropion and Ectropion Repai), Application (Patient Education and Information Apps, Surgical Simulation and Training ...
$ 3500
Chromhidrosis Treatment Comprehensive Study by Type (Botox, Liposuction, Surgery, Home remedies, Others), Application (Hospitals and Clinics, Specialty and Dermatology Clinics, Others), Chromhidrosis...
$ 3450